Blair William & Co. IL Buys Shares of 2,943 Balchem Corporation (NASDAQ:BCPC)

Blair William & Co. IL bought a new stake in Balchem Corporation (NASDAQ:BCPC) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 2,943 shares of the basic materials company’s stock, valued at approximately $489,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in BCPC. US Bancorp DE raised its holdings in shares of Balchem by 36.8% in the 1st quarter. US Bancorp DE now owns 8,859 shares of the basic materials company’s stock valued at $1,471,000 after buying an additional 2,382 shares during the period. Nicolet Advisory Services LLC raised its holdings in shares of Balchem by 5.3% in the 1st quarter. Nicolet Advisory Services LLC now owns 4,360 shares of the basic materials company’s stock valued at $681,000 after buying an additional 221 shares during the period. Natixis Advisors LLC raised its holdings in shares of Balchem by 7.6% in the 1st quarter. Natixis Advisors LLC now owns 24,336 shares of the basic materials company’s stock valued at $4,040,000 after buying an additional 1,721 shares during the period. XTX Topco Ltd purchased a new stake in shares of Balchem in the 1st quarter valued at $855,000. Finally, Mackenzie Financial Corp raised its holdings in shares of Balchem by 20.4% in the 1st quarter. Mackenzie Financial Corp now owns 4,625 shares of the basic materials company’s stock valued at $768,000 after buying an additional 785 shares during the period. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. HC Wainwright reiterated a “buy” rating and issued a $189.00 price objective (up previously from $180.00) on shares of Balchem in a report on Monday, August 4th. Wall Street Zen cut Balchem from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th.

Balchem Trading Down 0.3%

BCPC opened at $158.88 on Tuesday. Balchem Corporation has a 12 month low of $145.70 and a 12 month high of $185.96. The stock has a market capitalization of $5.16 billion, a price-to-earnings ratio of 36.44, a PEG ratio of 3.40 and a beta of 0.88. The company has a debt-to-equity ratio of 0.17, a current ratio of 2.64 and a quick ratio of 1.57. The business has a fifty day moving average price of $159.03 and a 200 day moving average price of $162.12.

Balchem (NASDAQ:BCPC) last released its earnings results on Thursday, July 31st. The basic materials company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.25 by $0.02. Balchem had a return on equity of 12.41% and a net margin of 14.48%. The firm had revenue of $255.47 million during the quarter, compared to analysts’ expectations of $250.31 million. During the same period in the previous year, the firm posted $1.09 EPS. Balchem’s revenue for the quarter was up 9.1% on a year-over-year basis. Sell-side analysts expect that Balchem Corporation will post 4.64 earnings per share for the current fiscal year.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.